Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Inspire Medical Systems (INSP) Gross Margin (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Gross Margin for 9 consecutive years, with 86.59% as the latest value for Q4 2025.

  • Quarterly Gross Margin rose 161.0% to 86.59% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 85.39% through Dec 2025, up 71.0% year-over-year, with the annual reading at 85.39% for FY2025, 71.0% up from the prior year.
  • Gross Margin hit 86.59% in Q4 2025 for Inspire Medical Systems, up from 85.85% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 86.59% in Q4 2025 to a low of 81.88% in Q3 2022.
  • Historically, Gross Margin has averaged 84.83% across 5 years, with a median of 84.84% in 2024.
  • Biggest five-year swings in Gross Margin: plummeted -414bps in 2022 and later skyrocketed 222bps in 2023.
  • Year by year, Gross Margin stood at 85.77% in 2021, then fell by -2bps to 83.94% in 2022, then grew by 2bps to 85.43% in 2023, then fell by -1bps to 84.99% in 2024, then increased by 2bps to 86.59% in 2025.
  • Business Quant data shows Gross Margin for INSP at 86.59% in Q4 2025, 85.85% in Q3 2025, and 84.03% in Q2 2025.